Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by ...
One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the ...
Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 524.46% and ...
Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.
The FDA put both peptides on its shortage list in 2022. Semaglutide is still on that list, while the FDA lifted its shortage ...
Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Here, we unpack the latest research on GLP ...
S&P 500, JPMorgan Chase & Co, Eli Lilly and Company, Novo Nordisk A/S Class B. Read Edison Group (Melanie Jenner)'s latest article on Investing.com UK.
CBS News reports that workplace violence at Allina Health's Abbott Northwestern Hospital has led to more than $83,000 in fines over the past year. Other news from the health industry is on the demand ...
Coffee hit a record high in New York, on mounting worries over a global supply crunch that have made it one of this year’s ...
The fighters who forced Bashar al-Assad into exile began the complex task of governing the Syrian capital. New York Times reporters entering the country saw relics of the deposed regime on the ...
Stock futures edged lower Monday morning as investors eye this week’s key inflation report. The Consumer Price Index (CPI) ...